Oscar Health Inc (N:OSCR)
Business Focus: Health Insurance
| Sector: Financials | Industry: Life & Health Insurance |
| See Regulatory Filings on SEC | |
| Company Contact | |
| Address: | 75 Varick Street, 5Th Floor NEW YORK NY 10013 |
| Tel: | N/A |
| Website: | https://www.hioscar.com |
| IR: | See website |
| Key People | ||
| Mark T. Bertolini Chief Executive Officer, Director | Joshua Kushner Vice Chairman of the Board, Co-Founder | Mario Schlosser Co-Founder, President - Technology, Director |
| R. Scott Blackley Chief Financial Officer | Ranmali Bopitiya Chief Legal Officer | Sean Martin Chief Medical Officer | Alessandrea C. Quane Chief Insurance Officer |
| Business Overview |
| Oscar Health, Inc. is a health insurance company, which has built a full stack technology platform focused on serving its members. It offers individual and family, and small group plans, and +Oscar, its full stack technology platform, to others within the provider and payor space. Its individual market primarily consists of policies purchased by individuals and families through health insurance marketplaces. The small group market consists of employees of companies with up to 50 full-time workers in various states and up to 100 full-time workers in select states. It offers health plans in the individual market on exchange and off-exchange under the five metal plan categories, such as catastrophic, bronze, silver, gold, and platinum. These plans differ based on the size of the monthly premium and the level of sharing of medical costs between Oscar and its members. Oscar brings insurance products to the market to meet various healthcare needs of consumers. |
| Financial Overview |
| For the fiscal year ended 31 December 2023, Oscar Health Inc revenues increased 48% to $5.86B. Net loss decreased 55% to $270.7M. Revenues reflect increase in net premium earned. Lower net loss reflects General and administrative expenses decrease of 11% to $207.9M (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$2.85 to -$1.22. |
| Employees: | 2,400 as of Dec 31, 2023 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $2,545M as of Dec 31, 2023 |
| Annual revenue (TTM): | $5,863M as of Dec 31, 2023 |
| EBITDA (TTM): | -$204.92M as of Dec 31, 2023 |
| Net annual income (TTM): | -$270.73M as of Dec 31, 2023 |
| Free cash flow (TTM): | -$297.74M as of Dec 31, 2023 |
| Net Debt Last Fiscal Year: | N/A |
| Shares outstanding: | 236,980,585 as of Apr 10, 2024 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.